Deep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients

June 4, 2024 New FDA-cleared AI-enabled applications include the industry's first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds First fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease Amsterdam, the Netherlands – Roya ...